📣 VC round data is live. Check it out!
- Public Comps
- Synthetic MR
Synthetic MR Valuation Multiples
Discover Synthetic MR's revenue and EBITDA valuation multiples and M&A history, alongside public comparables like VSee Health, Pheton Holdings, AMA Corp, Genomed and more.
Synthetic MR Overview
About Synthetic MR
Synthetic MR AB develops software solutions for Magnetic Resonance Imaging that support shorter exam times and deliver more information to the clinician. Its product is available in different packages. SyMRI IMAGE provides high MRI workflows and enables automatic segmentation of brain tissue, providing objective decision support, MAGiC is a customer-specific version of SyMRI IMAGE marketed and sold by GE Healthcare under a license agreement, SyMRI NEURO includes contrast images, biomarker segmentation, volumetric measurements of brain tissues and quantitative parametric maps, and SyMRI Research Edition includes contrast images, volumetric measurements and quantitative maps to provide more information to the researcher.
Founded
2007
HQ

Employees
40
Website
Financials (LTM)
EV
$5M
Valuation Multiples
Start free trialSynthetic MR Financials
Synthetic MR reported last 12-month revenue of $7M and negative EBITDA of ($2M).
In the same LTM period, Synthetic MR generated ($3M) in gross profit, ($2M) in EBITDA losses, and had net loss of ($4M).
Revenue (LTM)
Synthetic MR P&L
In the most recent fiscal year, Synthetic MR reported revenue of $6M and EBITDA of ($3M).
Synthetic MR is unprofitable as of last fiscal year, with gross margin of 109%, EBITDA margin of (49%), and net margin of (93%).
Financial data powered by Morningstar, Inc.
Synthetic MR Stock Performance
Synthetic MR has current market cap of $8M, and enterprise value of $5M.
Market Cap Evolution
Synthetic MR's stock price is $0.09.
Synthetic MR share price increased by 1.3% in the last 30 days, and decreased by 73.6% in the last year.
Synthetic MR has an EPS (earnings per share) of $-0.07.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $5M | $8M | 4.6% | 1.3% | -1.5% | -73.6% | $-0.07 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialSynthetic MR Valuation Multiples
Synthetic MR trades at 0.7x EV/Revenue multiple, and (2.4x) EV/EBITDA.
EV / Revenue (LTM)
Synthetic MR Financial Valuation Multiples
As of June 3, 2026, Synthetic MR has market cap of $8M and EV of $5M.
Synthetic MR has a P/E ratio of (1.9x).
Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Synthetic MR Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.


Synthetic MR Margins & Growth Rates
Synthetic MR grew revenue by 8% but EBITDA decreased by 84% in the last fiscal year.
In the most recent fiscal year, Synthetic MR reported gross margin of 109%, EBITDA margin of (49%), and net margin of (93%).
Synthetic MR Margins
Synthetic MR Growth Rates
Data powered by FactSet, Inc. and Morningstar, Inc.
Synthetic MR Operational KPIs
Synthetic MR's revenue per employee in the last FY averaged $0.2M, while opex per employee averaged $0.3M for the same period.
Synthetic MR's Rule of 40 is 4% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Synthetic MR's Rule of X is 20% (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Data powered by FactSet, Inc. and Morningstar, Inc.
Synthetic MR Competitors
Synthetic MR competitors include VSee Health, Pheton Holdings, AMA Corp, Genomed, Media Lab, Induct, Vidavo, NRGene, Kontigo Care and Brainscan.
Most Synthetic MR public comparables operate across Medical Imaging & Diagnostics, Healthcare Software, HealthTech, B2B SaaS, Vertical SaaS and Longevity.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| 0.6x | - | (1.0x) | - | |||
| - | - | - | - | |||
| 3.6x | - | (1.4x) | - | |||
| 0.9x | - | 5.6x | - | |||
| 4.1x | - | 13.3x | - | |||
| 4.0x | - | 8.1x | - | |||
| 3.9x | - | 10.3x | - | |||
| 1.8x | - | (5.8x) | - | |||
This data is available for Pro users. Sign up to see all Synthetic MR competitors and their valuation data. Start Free Trial | ||||||
Acquisitions by Synthetic MR
Synthetic MR has acquired 1 company to date.
Last acquisition by Synthetic MR was on November 28th 2024. Synthetic MR acquired Combinostics for $5M (EV/Revenue multiple available to Pro users).
Latest Acquisitions by Synthetic MR
| Description | Combinostics is a Tampere, Finland-based medical software company developing AI-assisted diagnostic tools for neurology. Its FDA-cleared cTAI platform analyzes brain CT scans to detect acute intracranial pathologies like stroke and hemorrhage, aiding radiologists in emergency settings across Europe and the US. |
| HQ Country | |
| HQ City | Tampere |
| Deal Date | 28 Nov 2024 |
| Valuation | $5M |
| EV/Revenue | |
| EV/EBITDA | |
This data is available for Pro users. Sign up to see all Synthetic MR acquisitions and their M&A valuation multiples. Start Free Trial | |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Synthetic MR
| When was Synthetic MR founded? | Synthetic MR was founded in 2007. |
| Where is Synthetic MR headquartered? | Synthetic MR is headquartered in Sweden. |
| How many employees does Synthetic MR have? | As of today, Synthetic MR has over 40 employees. |
| Is Synthetic MR publicly listed? | Yes, Synthetic MR is a public company listed on Nasdaq Stockholm. |
| What is the stock symbol of Synthetic MR? | Synthetic MR trades under SYNT ticker. |
| When did Synthetic MR go public? | Synthetic MR went public in 2013. |
| Who are competitors of Synthetic MR? | Synthetic MR main competitors include VSee Health, Pheton Holdings, AMA Corp, Genomed, Media Lab, Induct, Vidavo, NRGene, Kontigo Care, Brainscan. |
| What is the current market cap of Synthetic MR? | Synthetic MR's current market cap is $8M. |
| What is the current revenue of Synthetic MR? | Synthetic MR's last 12 months revenue is $7M. |
| What is the current revenue growth of Synthetic MR? | Synthetic MR revenue growth (NTM/LTM) is 13%. |
| What is the current EV/Revenue multiple of Synthetic MR? | Current revenue multiple of Synthetic MR is 0.7x. |
| Is Synthetic MR profitable? | No, Synthetic MR is not profitable. |
| What is the current EBITDA of Synthetic MR? | Synthetic MR has negative EBITDA and is not profitable. |
| What is Synthetic MR's EBITDA margin? | Synthetic MR's last 12 months EBITDA margin is (31%). |
| What is the current EV/EBITDA multiple of Synthetic MR? | Current EBITDA multiple of Synthetic MR is (2.4x). |
| What is the current FCF of Synthetic MR? | Synthetic MR's last 12 months FCF is ($2M). |
| What is Synthetic MR's FCF margin? | Synthetic MR's last 12 months FCF margin is (26%). |
| What is the current EV/FCF multiple of Synthetic MR? | Current FCF multiple of Synthetic MR is (2.8x). |
| How many companies Synthetic MR has acquired to date? | As of June 2026, Synthetic MR has acquired 1 company. |
| What was the largest acquisition by Synthetic MR? | $5M acquisition of Combinostics on 28th November 2024 was the largest M&A Synthetic MR has done to date. |
| What companies Synthetic MR acquired? | Synthetic MR acquired Combinostics. |
| In how many companies Synthetic MR has invested to date? | Synthetic MR hasn't invested in any companies yet (or none have been disclosed publicly). |
See public comps similar to Synthetic MR
Lists including Synthetic MR
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.
